About Us

Cannabis Orchards, located in Ottawa, Canada, holds a plant breeding industrial hemp license since 2018. The license includes the cultivation, import, export, sale and production of hemp seed and flower, as well as the cultivation of unapproved cultivars for the purposes of registration, research and field testing.

Under the supervision of our certified plant breeder, we have a breeding program which aims to develop varieties producing minor cannabinoids, as well as high CBD, low THC varieties. Our internal breeding program has already led to potential candidates currently undergoing further testing.

For more information on procuring seeds or plant matter from CBD or CBG-rich varieties, please contact us for more details.

Introduction of the first CBG variety and feminized seed to the Canadian hemp industry.

We hold the exclusive rights to Panakeia, the only CBG and THC-free hemp variety available worldwide. Exclusivity covers production and sale of seed, clone and plant matter in Canada. This variety contains up to 18% CBG and 0.00% THC. We have successfully conducted outdoor field studies and have submitted for addition to the LOAC in November 2020. We anticipate approval in Feb 2021. This will be the first CBG variety to be approved by Health Canada on the list of approved cultivars. Interested in purchasing seed or plant matter? Please contact us for more details!


Feminized seed production

Our team specializes in indoor feminized seed production. Using our in-house protocol and under our plant breeding license, we can produce feminized seed for any industrial hemp variety. We produce feminized seeds under the new standards set by the Canadian Seed Growers Association for the production of pedigreed seed. If you would like us to produce feminized seed for your variety, please contact us for more details.

Passion to help those in need

We are motivated to provide new therapeutic options to those currently left out by the Canadian offering. With a clinical background and affiliation with the major hospitals in the Ottawa region, we can bring these hemp varieties directly to patients in need.

We are affiliated with the pediatric neurology department at our local children’s hospital with interest in pursuing a trial of the CBG, THC-free variety in children with Dravet syndrome. Many families are awaiting this trial with anticipation given its potential in reducing seizure burden without psychoactive side-effects.


Industrial applications and export

Our projects have many applications, especially with the first CBG hemp variety to be introduced to the Canadian market. Given the 0.00% THC content, this will be an attractive offering to food, beverage, health supplements and cosmetics companies.

If you are outside of Canada and interested in importing our seeds or biomass, please contact us.

Meet The Team

Jamie Ghossein


B. Sc., MD candidate


David Murtagh

VP, Cultivation

Hari Nair

Certified Plant Breeder

B. Sc., M. Sc., PH. D.


Dr. Nair is a certified plant breeder with the Canadian Seed Grower’s Association (CSGA). After joining the company in 2020, he oversees the internal breeding program, certification of new varieties with Health Canada and the CSGA as well as import/exports.

Jamie, a 4th year medical student at the University of Ottawa, leads the company strategy, especially where it pertains to R&D. Whether it be in the clinic through various partnerships with local hospitals, or with major universities for wet lab research, his direction ensures Cannabis Orchards remains on the cutting edge of therapeutic development.

David Murtagh brings years of experience as an independent breeder and hemp cultivator. His expertise in breeding led to the development of new CBD cultivars currently under testing. His background in both the agricultural and construction industry allows Cannabis Orchards to operate large scale cultivation and breeding programs with efficiency.

Jacob Varney

VP, Research

B. Sc., PH. D. candidate


Jacob Varney is a PH. D. candidate at McGill. He leads many research projects in collaboration with the public sector. He is currently leading projects at the University of Ottawa and McGill on the development of gene editing protocols, pollen blocking and evaluating the interaction of endophytes with Cannabis.

Rachael Cranston

Communications Director & Media Relations

Rachael is an Environmental studies and technology Candidate at Carleton University. Her background in the environmental, technological and agricultural sectors directly bring support to every aspect of the Cannabis Orchards team. 

Cannabis Orchards Inc